HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > DermaLastyl

Print e mail rss del Y! myWeb Tweet
 

First anti-aging aftershave helps prevent onset of new facial lines, helps restore youthful appearance

DermaLastyl-m Aftershave aids in preventing the onset of new facial lines in men.

(EMAILWIRE.COM, May 09, 2008 ) New York – The first and only anti-wrinkle, anti-aging aftershave, DermaLastyl-m, is now available. Using genuine human elastin, Elastatropin, to help decrease the appearance of existing wrinkles and restore youthful appearance, DermaLastyl-m Aftershave aids in preventing the onset of new facial lines. Independent studies of the DermaLastyl patented delivery system note significant uptake of synthetic human elastin into the outer skin layers. Men can reduce their need to schedule wrinkle-eradicating risky injections and surgical procedures by using the new DermaLastyl-m Aftershave.



The primary active ingredient is a complex chain of over 600 amino acids. Such complex molecules are normally too large to work in a topical cosmetic application. Even the most advanced cosmetics sold contain much smaller peptide combinations totaling six amino acids at most. DermaLastyl-m is not yet in stores but can be purchased online at http://www.dermalastyl-m.com/ or by calling 800-335-8312. Distribution will be expanded to include retail and department stores worldwide in the coming months.



About DermaPlus, Inc.

DermaPlus, Inc., the producer of DermaLastyl line of products, is a biotechnology company that designs and manufactures sophisticated, high performance biomaterials for use in cosmeceuticals. Based on human genetic sequences, these biomaterials can be customized to reflect the genetic makeup of human tissues, population groups or even single individuals. DermaLastyl-B, DermaLastyl-E, DermaLastyl-Bx, DermaLastyl-Ex, Keracyte-b, and DermaLastyl-m are the first genetically engineered products on the market that help restore elastin properties to the skin. Used properly, DermaLastyl will eliminate and/or prevent wrinkles reducing the need or extending the life of cosmetic medical procedures such as Botox injections or facelifts.



Media Contact:

Jerry Jennings

Emerson Gerard Associates

561-881-7318

mediareply@emersongerard.com


###

This press release was issued through GroupWeb EmailWire.Com. For more information on unlimited press release distribution for $499/year, go to http://www.emailwire.com

Contact Information:
DermaLastyl
Jerry Jennings
Tel: 561-881-7318
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising




 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012